Loading organizations...
Loading organizations...
Clinical-stage biopharmaceutical company developing RNAi therapeutics.
Sirnaomics has raised $267.0M across 5 funding rounds.
Sirnaomics has raised $267.0M in total across 5 funding rounds.
Sirnaomics has raised $267.0M in total across 5 funding rounds.
Sirnaomics's investors include Rotating Boulder Fund, Donald Dai, shi shenghao, Yunchun Li, Alpha Win Capital, HongTao Capital, Longmen Capital, Sangel Capital, Da LIU, MBA and RPH, Legend Sky Investment, Rich Yield Capital, Rolling Boulder Investment.
Sirnaomics has raised $267.0M across 5 funding rounds. Most recently, it raised $105.0M Series E in July 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2021 | $105.0M Series E | Rotating Boulder Fund | |
| Oct 26, 2020 | $105.0M Series D | Donald Dai, shi shenghao, Yunchun Li | Alpha Win Capital, HongTao Capital, Longmen Capital, Sangel Capital |
| Apr 26, 2019 | $22.0M Series C | Da LIU, MBA and RPH | Legend Sky Investment, Rich Yield Capital, Rolling Boulder Investment |
| Jun 6, 2018 | $25.0M Series C | HuaKong Equity Investment, Qianhai Shenghui Investment, Sangel Capital | |
| May 4, 2016 | $10.0M Series B | Value Measured Investment |